DUBLIN–(BUSINESS WIRE)–The “Biologic API CDMO Benchmarking for New & Emerging Biopharma” report has been added to ResearchAndMarkets.com’s offering.
Biological drugs have transformed the practice of medicine in a relatively short period of time, encouraging investment and an increase of start-ups focused on biologics. This report takes a closer look at the new and emerging biopharma landscape within the biologics space. This analysis will help new and emerging biopharma companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies to better accommodate this segment.
The publisher understands the need for a deeper dive regarding the new and emerging biopharma landscape. This report provides pharmaceutical companies and contract manufacturers comprehensive analysis of current outsourcing trends and practices, CMO selection drivers, and CMO perceptions and interactions specific to the new and emerging audience. Findings are based on 119 service encounters from 45 respondents who have been involved in outsourced large molecule API projects in the past 18 months.
What you will learn:
New and Emerging Drug Developers:
Uncover which CMO attributes drive outsourcing partner selection for outsourced large molecule API manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peers
Gain insight into CMO customer loyalty, based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience
Make a more educated purchase of CMO services by understanding which manufacturers best fit your company’s needs
Contract Manufacturers:
Understanding your company’s competitive positioning and market awareness, and use this information to develop targeted messaging to new and emerging biopharma companies
Gain insight into drug developers’ outsourcing preferences and practices when it comes to CMO selection and CMO preference for outsourced large molecule API manufacturing
Major Topics:
Outsourcing Philosophies and Practices
CMO Selection Drivers
CMO Perceptions and Interactions
Study Data
Demographics
Key Topics Covered:
Copyright and Usage Guidelines
How to Use this Report
Analysis Note: Outsourcing Requirement
Introduction
Methodology
Respondent Demographics and Qualifications
Major Sections
Outsourcing Philosophies and Practices
Primary Section Takeaways
Outsourced Manufacturing Activities
Outsourcing Drivers
Preferred Providers
Number of Preferred Providers
Outsourcing Models
Large Molecule Product Offering
Large vs Small Molecule Outsourcing
CMO Selection Drivers
Primary Section Takeaways
Most Important CMO Attributes
CMO Attributes Gaining Importance
CMO Perceptions and Interactions
Primary Section Takeaways
CMO Familiarity
CMO Leaders – Unprompted
CMO Leaders – Prompted
Received Proposals
CMO Use
CMO Preference
CMO Preference Among Users
CMO Cost Perceptions
Summary Table
CMO Loyalty
Study Data
Outsourced Manufacturing Activities
Outsourcing Drivers
Use of Preferred Providers
Number of Preferred Providers
Outsourcing Models
Large Molecule Product Offering
Large vs Small Molecule Outsourcing
CMO Selection Attributes
CMO Selection Attributes Gaining Importance
CMO Familiarity
CMO Leaders – Unprompted
Other Responses (2%)
CMO Leaders – Prompted
Received Proposals
CMO Use
CMO Preference
CMO Cost Perceptions
Demographics
Company Type
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Biologic Drug Substance Outsourcing
Contract Manufacturing Responsibilities
Involvement in Outsourced Manufacturing
Contract Manufacturing Involvement
Years of Industry Experience
For more information about this report visit https://www.researchandmarkets.com/r/qigsa5
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900